Brind.

Jazz Pharmaceuticals is facing inquiries from Bank of America regarding tariff risks and company matters.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Jazz Pharmaceuticals Bank of America

Keep exploring

The entities involved

Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
- Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55
Bank of America
American multinational banking and financial services corporation
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
- Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26

Related events

Bank of America strategist Subramanian issued market targets and risk assessments on August 28, 2026.Aug 29

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet